Ad www.AngelOne.in
FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Ad www.AngelOne.in
Right Issue Status: Closed [2nd May 2023 to 31st May 2023]
Earum Pharmaceuticals Limited offers Right Issue size of Rs 49.34 Cr. Opening subscription soon. The company issues 04 right equity shares for every 01 equity shares held on the record date that is not decided. The face value of a share is Rs.2 per share and the right issue price is fixed at Rs.2 per share. Stay updated with us to know more about the Earum Pharmaceuticals Limited Right Issue Details 2022 including issue size, right issue entitlement, terms of payment, and more.
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
| Earum Pharmaceuticals Issue Details | Values |
|---|---|
| Category | RightIssue |
| Right Issue Issue Size (Shares) | 24.67 Cr Shares |
| Right Issue Issue Size (Amount) | ₹49.34 Cr |
| Face Value | ₹2 Per Equity Share |
| Right Issue - Issue Price | ₹2 per share |
| Right Issue Record Date | 10th Apr 2023 |
| Right Issue Entitlement | 4 Equity Shares for every 1 Equity Shares held on the Record Date |
| Right Issue Terms of payment | Investors will have to pay Rs. 0.50 at the time of allotment, Rs. 0.50 at the time of 1st Call, Rs. 0.50 at the time of 2nd Call and Rs. 0.50 at the time of 3rd and Final Call. |
| Listing At | BSE |
| BSE Code | 542724 |
| NSE Code |
In this section we have covered all important dates related to Earum Pharmaceuticals Right Issue. Dates are updated as they are announced. The most noted dates are Right Issue start date and Right Issue end date, which one should use to participate in Right Issue.
| Right Issue Activity | Date |
|---|---|
| Right Issue Issue Open Date | 2nd May 2023 |
| Right Issue Issue Close Date | 31st May 2023 |
| Basis of Allotment Finalisation Date* | 10th Jun 2023 |
| Refunds Initiation* | 26th May 2023 |
| Credit of Shares to Demat Account* | 16th Jun 2023 |
| Right Issue Listing Date* | 20th Jun 2023 |
* - Tentative Dates
Zerodha Trade@20
Earum Pharmaceuticals was incorporated in 2012 and engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections.
They have a long record of accomplishment of manufacturing pharmaceutical dosage forms for worldwide pharmaceutical markets. Earum has a very good manufacturing infrastructure consisting of modern WHO-GMP Certified manufacturing facilities and the products are as per IP/BP/USP standards & specifications.
Earum Pharmaceuticals is a market leader in making quality healthcare and consumer products affordable and available across the globe including whole Africa, Latin America and South East Asia. We accomplish this by having WHO approved production facilities in India and by focusing on our first-class distribution expertise.
Past performance and financial results of Earum Pharmaceuticals.
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Reserves and Surplus |
|---|---|---|---|---|
| 31-Mar-20 | 36.16 | 57.38 | 1.82 | 8.25 |
| 31-Mar-21 | 27.87 | 50.02 | 0.09 | 8.33 |
| 31-Mar-22 | 28.79 | 28.74 | 2.22 | 4.39 |
| Amount in ₹ Crore | ||||
The table below is live update of Right Issue bidding details from NSE and BSE.
Earum Pharmaceuticals Right Issue Offer Document (Letter of Offer) >>Document
Earum Pharmaceuticals Right Issue Offer Document (Letter of Offer) >>Earum Pharmaceuticals Right Issue Red Herring Prospectus is not yet available.
Earum Pharmaceuticals Right Issue Online Application (Registrar & Transfer Agent) >>Online Application
Earum Pharmaceuticals Right Issue Online Application (Registrar & Transfer Agent) >>Earum Pharmaceuticals Right Issue RTA information is not yet available.
Last Updated on 2023-06-03T03:30:44+00:00
